Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Exclusives

Exclusives

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Exclusives
  • Interview

EXCLUSIVE: Joby Aviation Executive Chairman, Paul Sciarra Now Interviewing On Benzinga’s Power Hour Show

By Zoltan Suranyi
Today, 10:59 PM
Click To Tune In: https://www.youtube.com/watch?v=1g5oNrtclSw

JOBY

Read More
1 minute read
  • Exclusives
  • Interview

EXCLUSIVE: FTAC Athena Acquisition Corp. Merger Partner Pico, Chairman, Founder and Co-CEO, Jarrod Yuster Now Interviewing On Benzinga’s SPACs Attack Show

By Zoltan Suranyi
Today, 10:59 PM
Click To Tune In Here: https://www.youtube.com/watch?v=yY9w_WI0uUE

FTAA

Read More
1 minute read
  • Exclusives
  • Interview

EXCLUSIVE: Definitive Healthcare Corp. Founder & CEO, Jason Krantz Now Interviewing On Benzinga’s Power Hour Show

By Zoltan Suranyi
Today, 10:59 PM
Click To Tune In Here... https://www.youtube.com/watch?v=w-SHDvfAGWE  

DH

Read More
1 minute read
  • Exclusives
  • Interview
  • Media

EXCLUSIVE: Inspirato CEO Says ‘We Think We’re In First Inning Of First Pitch Of Subscription Travel,’ Believes ‘People In 10 Years Will Be Talking About Subscription Travel The Same Way People Talk About Telecom Today’

By Benzinga Newsdesk
Today, 10:59 PM
https://www.youtube.com/watch?v=FhtZAvjREnc

TVAC

Read More
1 minute read
  • Exclusives
  • Interview
  • Media

EXCLUSIVE: Inspirato CEO Says ‘Our Subscriptions Pay Us A Loyalty,’ ‘Average Inspirato Buyer Can Be Very Flexible…Has Timeline Of About 5 Years’

By Benzinga Newsdesk
Today, 10:59 PM
https://www.youtube.com/watch?v=FhtZAvjREnc

TVAC

Read More
1 minute read
  • Exclusives
  • Interview
  • Media

EXCLUSIVE: Inspirato CEO Says ‘We’re Gonna Make Path Much, Much Better,’ Admits Path Was Not Created For Pandemic Environment, Indicates Will Make ‘Big Investments’ Into Technology, Inventory Side

By Benzinga Newsdesk
Today, 10:59 PM
https://www.youtube.com/watch?v=FhtZAvjREnc

TVAC

Read More
1 minute read
  • Exclusives
  • Interview
  • Media

EXCLUSIVE: Inspirato CEO Says Co.’s Path Platform Is Growth Engine For Inspirato Moving Forward, Calls Path ‘Highly Shareable’

By Benzinga Newsdesk
Today, 10:59 PM
https://www.youtube.com/watch?v=FhtZAvjREnc

TVAC

Read More
1 minute read
  • Exclusives
  • Interview
  • Media

EXCLUSIVE: Inspirato CEO Highlights Yesterday’s Launch Of Inspirato Real Estate, Says Is The Place ‘Where We Provide Homes We Want People To Buy For Us’

By Benzinga Newsdesk
Today, 10:59 PM
https://www.youtube.com/watch?v=FhtZAvjREnc

TVAC

Read More
1 minute read
  • Exclusives
  • Interview

EXCLUSIVE: Thayer Ventures Acquisition Corp. Merger Partner, Inspirato CEO, Brent Handler Now Interviewing On Benzinga’s SPACs Attack Show

By Zoltan Suranyi
Today, 10:59 PM
Click To Tune In Here..https://www.youtube.com/watch?v=FhtZAvjREnc

TVAC

Read More
2 minute read
  • Biotech
  • Exclusives
  • General
  • Health Care
  • News
  • Penny Stocks

EXCLUSIVE: Ampio’s Ampion Shows Benefit In Late-Stage Knee Osteoarthritis Study

By Vandana Singh
Today, 10:59 PM
Ampio Pharmaceuticals Inc (NYSE: AMPE) has reported top-line results from the AP-013 Phase 3 trial evaluating the Company's intra-articular (IA) injection of Ampion in adults with pain due to severe osteoarthritis of the knee (OAK). 

AMPE

Posts navigation

Previous 1 … 113 114 115 … 137 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service